CClinicalTrials.gg
RecruitingNCT01204944STCSUpdated Nov 29, 2023

Swiss Transplant Cohort Study

An observational study in All Transplanted Individuals in Switzerland, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 0 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-11-29.

Sponsored by University of Zurich · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
7,500
Ages
0 Years to 100 Years
Sex
All
01

Study summary

The Swiss Transplant Cohort Study is an observational prospective cohort study enrolling all patients after solid organ and stem cell transplantation since 5/2008 in Switzerland. Predefined variables are collected at defined time points. Individual samples (PBMC, plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome with emphasis on immunological and infectious complications as well as psychosocial variables will be gathered.

02

Conditions studied

  • All Transplanted Individuals in Switzerland
03

In context

Lead sponsor

University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All transplanted indivduals in Switzerland

Inclusion criteria

  • All patients after organ and stem cell (planned 2009) transplantation.

Exclusion criteria

Exclusion criteria:

  • No informed consent given
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
7,500 participants (estimated)
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Outcome after transplantation

    Various endpoints

    Time frame: open

07

Study locations

1 of 1 sites recruiting
  • Zurich, Switzerland
    Recruiting
08

References and documents

Publications

  • Branca-Dragan S, Koller MT, Danuser B, Kunz R, Steiger J, Hug BL. Evolution of disability pension after renal transplantation: methods and results of a database linkage study of the Swiss Transplant Cohort Study and Swiss Disability Insurance. Swiss Med Wkly. 2021 Sep 23;151:w30027. doi: 10.4414/smw.2021.w30027. eCollection 2021 Sep 13. PubMed 34558884 ↗
  • Krisl A, Stampf S, Hauri D, Binet I, Mueller T, Sidler D, Hadaya K, Golshayan D, Pascual M, Koller M, Dickenmann M, The Swiss Transplant Cohort Study Stcs. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study. Swiss Med Wkly. 2020 Dec 5;150:w20354. doi: 10.4414/smw.2020.20354. eCollection 2020 Nov 30. PubMed 33277913 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01204944
Lead sponsor
University of Zurich
Collaborators
University of Bern, University of Basel, University of Lausanne, Cantonal Hospital of St. Gallen, University Hospital, Geneva
Responsible party
Nicolas Mueller (Head, Zurich University Hospital Transplant Center, University of Zurich) — Principal investigator
First posted
Sep 17, 2010
Start date
May 2008
Primary completion
May 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Nov 29, 2023

Study contacts

01 Studienregister MasterAdmins
Contact
+41 (0)44 255 11 11
01 Studienregister MasterAdmins
study director · UniversitaetsSpital Zuerich

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion